RV1729 - J&J
JNJ: Pharmaceutical Business Review (J&J) - May 24, 2015 - Anticipated regulatory filing for COPD during 2020-2024 
Anticipated regulatory • Immunology
http://www.investor.jnj.com/webcasts-presentations.cfm
 
May 24, 2015
 
.
 
d20eb86c-59af-44d4-8442-09c4a887d5f0.jpg